WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics's investors include Y Combinator, Omnes Capital, Debiopharm Group.
WhiteLab Genomics is headquartered in Paris, France.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"WhiteLab Genomics — Funding & Investors." VCBacked, September 12, 2022, https://www.vcbacked.co/company/whitelab-genomics. Accessed September 30, 2026.
VCBacked. (2022). WhiteLab Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/whitelab-genomics
{{cite web |title=WhiteLab Genomics — Funding & Investors |url=https://www.vcbacked.co/company/whitelab-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated